Table 2.
Clinical laboratory results of case 2.
| Measure | Patient on admission |
Transferred to ICU |
Day 18 | Day 21 | Day 33 | Day 34 | Day 35 | Day 36 | Reference range |
|---|---|---|---|---|---|---|---|---|---|
| Blood Pressure (mmHg) | 108/71 | 127/97 | 119/80 | 119/80 | 113/81 | 117/84 | 131/80 | 125/90 | 90–140/60–90 |
| Pulse (beats/min) | 100 | 70 | 117 | 90 | 120 | 88 | 107 | 110 | 60–100 |
| Pulse oxygen saturation (%) | NA | 99 | 100 | 99 | 97 | 100 | 95 | 94 | ≥95 |
| Respiratory rate (breaths/min) | 20 | 17 | 22 | 26 | 35 | 13 | 29 | 33 | 12–20 |
| White blood cell count (109/L) | 4.06 | 6.7 | 6.7 | 9.23 | 5.55 | 3.42 | 2.01 | 5.06 | 4.3–5.8 |
| Neutrophil (%) | 87 | 95.3 | 95.7 | 99.3 | 96.3 | 95.1 | 86.1 | 87.7 | 40–75 |
| Red blood cell (1012/L) | 2.55 | 3.09 | 3.13 | 3.08 | 2.89 | 2.63 | 3.26 | 2.55 | 3.5–9.5 |
| Hemoglobin (g/dL) | 72 | 85 | 87 | 84 | 86 | 79 | 96 | 77 | 130–175 |
| Red blood cell specific volume | NA | 0.269 | 0.271 | 0.277 | 0.265 | 0.236 | 0.283 | 0.222 | 0.4–0.5 |
| Platelet count (109/L) | 24 | NA | 105 | 86 | 36 | 52 | 23 | 24 | 125–350 |
| C-reactive protein (mg/L) | 4.67 | 32.03 | 21.52 | 23.9 | 2.58 | 1.81 | 1.28 | 1.41 | 0–10 |
| Serumamyloid A (mg/L) | NA | >200 | >200 | >200 | 33.1 | 18.97 | 6.22 | 109 | <10 |
| Procalcitonin (ng/mL) | 1.28 | 3.06 | 2.1 | 0.625 | NA | 1.28 | 0.798 | 0.617 | <0.05 |
| Alanine aminotransferase (U/L) | 87 | 22 | 31 | 38 | 14 | 27 | NA | NA | 9–50 |
| Aspertate Aminotransferase (U/L) | 45 | 37 | 50 | 55 | 31 | 66 | NA | NA | 15–40 |
| Albumin (g/L) | 29.7 | 32.82 | 31.4 | 29.9 | 27.6 | 27.9 | NA | NA | 40–55 |
| Total bilirubin (μmol/L) | 10.5 | 12.38 | 11.64 | 13.66 | 9.73 | 8.4 | NA | NA | 0–23 |
| Direct bilirubin (μmol/L) | NA | 5 | 4.2 | 5.2 | 4.6 | 3.8 | NA | NA | 0–8 |
| Sodium (mmol/L) | NA | 146 | 150 | 141 | 151 | 151 | NA | NA | 137–147 |
| Potassium (mmol/L) | NA | 3.7 | 3.96 | 5.95 | 6.42 | 4.42 | NA | NA | 3.5–5.3 |
| Chloride (mmol/L) | NA | 110.9 | 118.6 | 113.9 | 115.1 | 112.2 | NA | NA | 99–110 |
| Calcium (mmol/L) | NA | 2 | 1.95 | 1.97 | 2.18 | 2.22 | NA | NA | 2.11–2.52 |
| Magnesium (mmol/L) | NA | 1.35 | 1.3 | 1.17 | 1.26 | 1.03 | NA | NA | 0.75–1.02 |
| Urea (mmol/L) | NA | 38.28 | 40.99 | 25.42 | 56.77 | 35.75 | NA | NA | 3.1–8 |
| Creatinine (μmol/L) | 213 | 239 | 234 | 199 | 235 | 145 | NA | NA | 57–97 |
| eGFR (mL/min) | NA | 26.44 | 27.12 | 32.99 | 26.98 | 48.37 | NA | NA | ≥90 |
| Prothrombin time (s) | NA | 15.2 | 15.2 | 15.9 | 12.8 | 12 | 11.6 | NA | 9–13 |
| Prothrombin time activity (%) | NA | 52.7 | 52.7 | 47 | 66.4 | 73.4 | 81.1 | NA | 75–135 |
| APTT (s) | NA | 33.3 | 32.5 | 31.7 | 34 | 46.6 | 50.6 | NA | 25–31.3 |
| Thrombin time (s) | NA | 18.3 | 21.6 | 19.6 | 68.4 | Non-clotting | 138 | NA | 14–21 |
| Fibrinogen (g/L) | NA | 1.18 | 0.81 | 1.39 | 1.12 | 1.14 | 0.71 | NA | 2–4 |
| D-Dimer (mg/L) | NA | 13.52 | 15.3 | 9.87 | 3.53 | 3.52 | 3.76 | NA | 0–0.5 |
| NT-pro BNP (pg/mL) | NA | 3164 | 7773 | 3535 | NA | 2492 | 2011 | 4769 | 0–125 |
| HCMV-DNA | 2.63E+5 | 8.43E+5 | NA | NA | NA | NA | NA | NA | NA |
| G6PD (U/L) | 702.2 | 1870.9 | 1045.7 | NA | 1334.5 | NA | NA | NA | NA |
TSM, Talaromycosis; AIDS, acquired immune deficiency syndrome; CT, computed tomography; HIV, human immunodeficiency virus; APTT, activated coagulation time of whole blood; NT-pro BNP, N-terminal pro B-type natriuretic peptide; NA, not obtained; ART, antiretroviral therapy; GM test, galactomannan test; G test, (1, 3)-β-D-glucan test; ICU, intensive care unit; HCMV-DNA, human cytomegalovirus; eGFR, estimated glomerular filtration rate.